FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Holtzman

Research Profile

Living Beings

Concepts & Ideas

Drug Dose Response Relationship

Chemicals & Drugs

Activities & Behaviors

Motor Activity

Physiology

Co-author Network

Publications

TOP 3
David A White; Michael Ballard; Alvin C Harmon; Stephen G Holtzman
Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
David A White; Clifford C Michaels; Stephen G Holtzman
Periadolescent male but not female rats have higher motor activity in response to morphine than do adult rats.
Clifford C Michaels; Stephen G Holtzman
Early postnatal stress alters place conditioning to both mu- and kappa-opioid agonists.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Holtzman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: David A White; Michael Ballard; Alvin C Harmon; Stephen G Holtzman
Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
Brain research bulletin 2008;76(6):597-604.
2008: David A White; Clifford C Michaels; Stephen G Holtzman
Periadolescent male but not female rats have higher motor activity in response to morphine than do adult rats.
Pharmacology, biochemistry, and behavior 2008;89(2):188-99.
2008: Clifford C Michaels; Stephen G Holtzman
Early postnatal stress alters place conditioning to both mu- and kappa-opioid agonists.
The Journal of pharmacology and experimental therapeutics 2008;325(1):313-8.
2007: Kelly H Skelton; Dana Oren; David A Gutman; Keith W Easterling; Stephen G Holtzman; Charles Nemeroff; Michael J Owens
The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.
European journal of pharmacology 2007;571(1):17-24.
2007: Clifford C Michaels; Keith W Easterling; Stephen G Holtzman
Maternal separation alters ICSS responding in adult male and female rats, but morphine and naltrexone have little affect on that behavior.
Brain research bulletin 2007;73(4-6):310-8.
2007: David A White; Mikhail Kalinichev; Stephen G Holtzman
Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat.
Brain research 2007;1149():141-8.
2007: Clifford C Michaels; Stephen G Holtzman
Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.
Pharmacology, biochemistry, and behavior 2007;86(4):784-96.
2006: Clifford C Michaels; Stephen G Holtzman
Neonatal stress and litter composition alter sucrose intake in both rat dam and offspring.
Physiology & behavior 2006;89(5):735-41.
2006: Andrew R Joyce; Keith W Easterling; Stephen G Holtzman; Michael J Kuhar
Modeling the onset of drug dependence: a consideration of the requirement for protein synthesis.
Journal of theoretical biology 2006;240(4):531-7.
2005: David A White; Stephen G Holtzman
Periadolescent morphine exposure alters subsequent behavioral sensitivity to morphine in adult rats.
European journal of pharmacology 2005;528(1-3):119-23.
2005: David A White; M Lisa Hwang; Stephen G Holtzman
Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.
Pharmacology, biochemistry, and behavior 2005;81(3):451-8.
2005: David A White; Stephen G Holtzman
Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
The Journal of pharmacology and experimental therapeutics 2005;314(1):374-82.
2004: Mikhail Kalinichev; David A White; Stephen G Holtzman
Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitization.
Psychopharmacology 2004;177(1-2):61-7.
2004: David A White; Mikhail Kalinichev; Stephen G Holtzman
Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. II. Agonist-induced antinociception and antagonist-induced suppression of fluid consumption.
Psychopharmacology 2004;177(1-2):68-78.
2004: Keith W Easterling; Stephen G Holtzman
In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation.
Psychopharmacology 2004;175(3):287-95.
2003: David A White; Stephen G Holtzman
Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
Psychopharmacology 2003;167(2):203-10.
2003: Stephen G Holtzman
Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
The Journal of pharmacology and experimental therapeutics 2003;304(3):1033-41.
2003: Mikhail Kalinichev; Keith W Easterling; Stephen G Holtzman
Long-lasting changes in morphine-induced locomotor sensitization and tolerance in Long-Evans mother rats as a result of periodic postpartum separation from the litter: a novel model of increased vulnerability to drug abuse?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(2):317-28.
2003: Mikhail Kalinichev; Stephen G Holtzman
Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
The Journal of pharmacology and experimental therapeutics 2003;304(2):603-9.
2002: Mikhail Kalinichev; Keith W Easterling; Stephen G Holtzman
Early neonatal experience of Long-Evans rats results in long-lasting changes in reactivity to a novel environment and morphine-induced sensitization and tolerance.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(4):518-33.
2002: Mikhail Kalinichev; Keith W Easterling; Paul M Plotsky; Stephen G Holtzman
Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats.
Pharmacology, biochemistry, and behavior 2002;73(1):131-40.
2002: Christina A Schad; Joseph B Justice; Stephen G Holtzman
Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.
The Journal of pharmacology and experimental therapeutics 2002;300(3):932-8.
2001: Keith W Easterling; Stephen G Holtzman
Central discriminative effects of morphine in rats: training via intracerebroventricular administration.
Brain research bulletin 2001;56(6):545-51.
2001: Mikhail Kalinichev; Keith W Easterling; Stephen G Holtzman
Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence.
Psychopharmacology 2001;157(3):305-12.
2001: David A White; Stephen G Holtzman
Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
The Journal of pharmacology and experimental therapeutics 2001;298(1):156-64.
2001: KR Powell; P Michael Iuvone; Stephen G Holtzman
The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine.
Pharmacology, biochemistry, and behavior 2001;69(1-2):59-70.
2001: Stephen G Holtzman
Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine.
Psychopharmacology 2001;155(2):180-6.
2001: Mikhail Kalinichev; Keith W Easterling; Stephen G Holtzman
Repeated neonatal maternal separation alters morphine-induced antinociception in male rats.
Brain research bulletin 2001;54(6):649-54.
2001: Heather L Kimmel; Stephen G Holtzman
Repeated cocaine administration does not alter morphine-induced rotational behavior in nigrally denervated rats.
Behavioural pharmacology 2001;12(2):101-8.
2001: KR Powell; Stephen G Holtzman
Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activity.
Drug and alcohol dependence 2001;62(1):83-90.
2000: Mikhail Kalinichev; Keith W Easterling; Stephen G Holtzman
Periodic postpartum separation from the offspring results in long-lasting changes in anxiety-related behaviors and sensitivity to morphine in Long-Evans mother rats.
Psychopharmacology 2000;152(4):431-9.
2000: Stephen G Holtzman
Further characterization of the discriminative stimulus effects of spiradoline.
Pharmacology, biochemistry, and behavior 2000;66(3):517-22.
2000: Keith W Easterling; R M Plovnick; Stephen G Holtzman
Acute opioid but not benzodiazepine dependence in rats responding for intracranial self-stimulation.
Psychopharmacology 2000;148(3):263-71.
2000: KR Powell; Stephen G Holtzman
Modulation of the discriminative stimulus effects of d-amphetamine by mu and kappa opioids in squirrel monkeys.
Pharmacology, biochemistry, and behavior 2000;65(1):43-51.
1999: KR Powell; L F Koppelman; Stephen G Holtzman
Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.
Behavioural pharmacology 1999;10(8):707-16.
1999: Laura A Volpicelli; Keith W Easterling; Heather L Kimmel; Stephen G Holtzman
Sensitization to daily morphine injections in rats with unilateral lesions of the substantia nigra.
Pharmacology, biochemistry, and behavior 1999;64(3):487-93.
1999: KR Powell; Stephen G Holtzman
Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
European journal of pharmacology 1999;377(1):21-8.
1999: Stephen G Holtzman
Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys.
European journal of pharmacology 1999;376(1-2):7-15.
1999: Keith W Easterling; Stephen G Holtzman
Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat.
The Journal of pharmacology and experimental therapeutics 1999;288(3):1269-77.
1999: A B Waddell; Stephen G Holtzman
Modulation of cocaine-induced antinociception by opioid-receptor agonists.
Pharmacology, biochemistry, and behavior 1999;62(2):247-53.
1998: Keith W Easterling; Stephen G Holtzman
Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
Psychopharmacology 1998;140(1):91-7.
1998: A B Waddell; Stephen G Holtzman
Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists.
Behavioural pharmacology 1998;9(5-6):397-407.
1998: Heather L Kimmel; Joseph B Justice; Stephen G Holtzman
Dissociation of morphine-induced potentiation of turning and striatal dopamine release by amphetamine in the nigrally-lesioned rat.
European journal of pharmacology 1998;346(2-3):203-8.
1998: Heather L Kimmel; C A Schad; Joseph B Justice; Stephen G Holtzman
Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats.
Brain research 1998;789(1):171-4.
1998: Heather L Kimmel; Stephen G Holtzman
Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat.
European journal of pharmacology 1998;343(2-3):119-27.
1998: KR Powell; Stephen G Holtzman
Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats.
Pharmacology, biochemistry, and behavior 1998;59(2):433-8.
1997: D R Woolfolk; Stephen G Holtzman
mu-, delta- and kappa-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats.
Drug and alcohol dependence 1997;48(3):209-20.
1997: Ronald J Tallarida; Heather L Kimmel; Stephen G Holtzman
Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine.
Psychopharmacology 1997;133(4):378-82.
1997: Heather L Kimmel; Ronald J Tallarida; Stephen G Holtzman
Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat.
Psychopharmacology 1997;133(4):372-7.
1997: A B Patterson; F J Gordon; Stephen G Holtzman
Naltrindole, a selective delta-opioid receptor antagonist, potentiates the lethal effects of cocaine by a central mechanism of action.
European journal of pharmacology 1997;333(1):47-54.
1997: Heather L Kimmel; Stephen G Holtzman
Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat.
The Journal of pharmacology and experimental therapeutics 1997;282(2):734-46.
1997: Stephen G Holtzman
Antagonism of morphine-like discriminative effects by beta-funaltrexamine.
Pharmacology, biochemistry, and behavior 1997;57(4):771-7.
1997: Stephen G Holtzman
Discriminative stimulus effects of buprenorphine in the rat.
Psychopharmacology 1997;130(3):292-9.
1997: Keith W Easterling; Stephen G Holtzman
Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists.
The Journal of pharmacology and experimental therapeutics 1997;281(1):188-99.
1997: Keith W Easterling; Stephen G Holtzman
Parametric changes in response equilibrium during an intra-cranial self stimulation (ICSS) task: can reward value be assessed independently of absolute threshold?
Neuroscience and biobehavioral reviews 1997;21(1):55-65.
1996: C A Schad; Joseph B Justice; Stephen G Holtzman
Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
Journal of neurochemistry 1996;67(6):2292-9.
1996: B E Garrett; Stephen G Holtzman
Comparison of the effects of prototypical behavioral stimulants on locomotor activity and rotational behavior in rats.
Pharmacology, biochemistry, and behavior 1996;54(2):469-77.
1996: Stephen G Holtzman
Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.
The Journal of pharmacology and experimental therapeutics 1996;277(2):739-46.
1995: Heather L Kimmel; B E Garrett; Stephen G Holtzman
Effects of acute and chronic morphine on rotational behavior in nigral-lesioned rats.
Pharmacology, biochemistry, and behavior 1995;52(2):397-401.
1995: D R Woolfolk; Stephen G Holtzman
Rat strain differences in the potentiation of morphine-induced analgesia by stress.
Pharmacology, biochemistry, and behavior 1995;51(4):699-703.
1995: B E Garrett; Stephen G Holtzman
Does adenosine receptor blockade mediate caffeine-induced rotational behavior?
The Journal of pharmacology and experimental therapeutics 1995;274(1):207-14.
1995: C A Schad; Joseph B Justice; Stephen G Holtzman
Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine.
European journal of pharmacology 1995;275(1):9-16.
1994: Stephen G Holtzman
Discriminative stimulus effects of dextromethorphan in the rat.
Psychopharmacology 1994;116(3):249-54.
1994: Stephen G Holtzman; G F Steinfels
Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.
Psychopharmacology 1994;116(3):243-8.
1994: M S Hooks; D N Jones; Stephen G Holtzman; Jorge L Juncos; Peter W Kalivas; Joseph B Justice
Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.
Psychopharmacology 1994;116(2):217-25.
1994: B E Garrett; Stephen G Holtzman
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
European journal of pharmacology 1994;262(1-2):65-75.
1994: C A Paronis; Stephen G Holtzman
Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
Psychopharmacology 1994;114(4):601-10.
1994: Stephen G Holtzman; G F Steinfels
Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist.
Pharmacology, biochemistry, and behavior 1994;47(3):575-8.
1994: D White-Gbadebo; Stephen G Holtzman
Acute sensitization to opioid antagonists.
Pharmacology, biochemistry, and behavior 1994;47(3):559-66.
1994: Stephen G Holtzman; G F Steinfels; W K Schmidt
Assessing spiradoline-like discriminative effects of DuP 747: influence of route of administration.
Pharmacology, biochemistry, and behavior 1994;47(3):487-91.
1994: D N Jones; Stephen G Holtzman
Behavioral effects of systemically administered mu and kappa opioid agonists in the squirrel monkey: peptides versus alkaloids.
Pharmacology, biochemistry, and behavior 1994;47(3):421-6.
1994: D White-Gbadebo; Stephen G Holtzman
Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone.
Psychopharmacology 1994;114(2):225-8.
1994: D N Jones; Stephen G Holtzman
Influence of naloxone upon motor activity induced by psychomotor stimulant drugs.
Psychopharmacology 1994;114(2):215-24.
1994: B E Garrett; Stephen G Holtzman
D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
Pharmacology, biochemistry, and behavior 1994;47(1):89-94.
1993: C A Paronis; A B Waddell; Stephen G Holtzman
Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
Pharmacology, biochemistry, and behavior 1993;46(4):813-7.
1993: D N Jones; W D Bowen; P S Portoghese; Stephen G Holtzman
Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine.
European journal of pharmacology 1993;249(2):167-77.
1993: D R Woolfolk; Stephen G Holtzman
Restraint stress potentiates analgesia induced by 5'-N-ethylcarboxamidoadenosine: comparison with morphine.
European journal of pharmacology 1993;239(1-3):177-82.
1993: D Levesque; Stephen G Holtzman
The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency or morphine are additive.
Brain research 1993;617(1):176-80.
1993: Stephen G Holtzman
Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
Pharmacology, biochemistry, and behavior 1993;44(2):349-55.
1992: D J Calcagnetti; Stephen G Holtzman
Intake of sweet water attenuates restraint-stress-induced potentiation of morphine analgesia in rats.
Brain research bulletin 1992;29(6):859-64.
1992: D N Jones; Stephen G Holtzman
Effects of naloxone infusion upon spontaneous and amphetamine-induced activity.
European journal of pharmacology 1992;221(1):161-5.
1992: M S Hooks; D N Jones; Joseph B Justice; Stephen G Holtzman
Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens.
Pharmacology, biochemistry, and behavior 1992;42(4):765-70.
1992: D N Jones; Stephen G Holtzman
Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors.
The Journal of pharmacology and experimental therapeutics 1992;262(2):638-45.
1992: C A Paronis; Stephen G Holtzman
Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
The Journal of pharmacology and experimental therapeutics 1992;262(1):1-9.
1992: D N Jones; Stephen G Holtzman
Long term kappa-opioid receptor blockade following nor-binaltorphimine.
European journal of pharmacology 1992;215(2-3):345-8.
1992: D J Calcagnetti; Stephen G Holtzman
Potentiation of morphine analgesia in rats given a single exposure to restraint stress immobilization.
Pharmacology, biochemistry, and behavior 1992;41(2):449-53.
1992: C A Paronis; Stephen G Holtzman
Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxone.
Life sciences 1992;50(19):1407-16.
1991: C A Paronis; Stephen G Holtzman
Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
The Journal of pharmacology and experimental therapeutics 1991;259(2):582-9.
1991: G K Mumford; Stephen G Holtzman
Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat.
The Journal of pharmacology and experimental therapeutics 1991;258(3):857-65.
1991: G K Mumford; Stephen G Holtzman
Do adenosinergic substrates mediate methylxanthine effects upon reinforcement thresholds for electrical brain stimulation in the rat?
Brain research 1991;550(1):172-8.
1991: Stephen G Holtzman; C W Young
Motor activity of squirrel monkeys measured with an ultrasonic motion sensor.
Pharmacology, biochemistry, and behavior 1991;38(3):633-7.
1991: Jill Adams; Stephen G Holtzman
Naltrexone-sensitizing effects of centrally administered morphine and opioid peptides.
European journal of pharmacology 1991;193(1):67-73.
1991: D J Calcagnetti; Stephen G Holtzman
Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
Pharmacology, biochemistry, and behavior 1991;38(1):185-90.
1991: Stephen G Holtzman
CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.
Life sciences 1991;49(21):1563-70.
1991: Stephen G Holtzman; S Mante; Kenneth P Minneman
Role of adenosine receptors in caffeine tolerance.
The Journal of pharmacology and experimental therapeutics 1991;256(1):62-8.
1991: Jill Adams; Stephen G Holtzman
Effects of receptor-selective opioids on operant behavior in morphine-treated and untreated rats.
Pharmacology, biochemistry, and behavior 1991;38(1):195-200.
1991: Stephen G Holtzman; L Cook; G F Steinfels
Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.
Psychopharmacology 1991;105(4):447-52.
1990: D J Calcagnetti; Stephen G Holtzman
Factors affecting restraint stress-induced potentiation of morphine analgesia.
Brain research 1990;537(1-2):157-62.
1990: Jill Adams; C A Paronis; Stephen G Holtzman
Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
The Journal of pharmacology and experimental therapeutics 1990;255(3):1027-32.
1990: G K Mumford; Stephen G Holtzman
Methylxanthines elevate reinforcement threshold for electrical brain stimulation: role of adenosine receptors and phosphodiesterase inhibition.
Brain research 1990;528(1):32-8.
1990: D J Calcagnetti; S W Fleetwood; Stephen G Holtzman
Pharmacological profile of the potentiation of opioid analgesia by restraint stress.
Pharmacology, biochemistry, and behavior 1990;37(1):193-9.
1990: I B Finn; P Michael Iuvone; Stephen G Holtzman
Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
Neuropharmacology 1990;29(7):625-31.
1990: Jill Adams; Stephen G Holtzman
Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.
The Journal of pharmacology and experimental therapeutics 1990;253(2):483-9.
1990: D J Calcagnetti; W D Bowen; Stephen G Holtzman
Stress-induced tolerance to delta receptor agonist DPDPE and selectivity of the irreversible delta-ligand, DALCE.
Brain research 1990;509(2):205-12.
1990: Jill Adams; Stephen G Holtzman
Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats.
Psychopharmacology 1990;100(4):451-8.
1989: Stephen G Holtzman
Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats.
Pharmacology, biochemistry, and behavior 1989;33(4):875-9.
1989: S W Fleetwood; Stephen G Holtzman
Stress-induced potentiation of morphine-induced analgesia in morphine-tolerant rats.
Neuropharmacology 1989;28(6):563-7.
1989: Stephen G Holtzman
Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
The Journal of pharmacology and experimental therapeutics 1989;248(3):1054-62.
1988: M Ukai; Stephen G Holtzman
Effects of intrahypothalamic administration of opioid peptides selective for mu-, kappa, and delta-receptors on different schedules of water intake in the rat.
Brain research 1988;459(2):275-81.
1988: G K Mumford; Darryl B Neill; Stephen G Holtzman
Caffeine elevates reinforcement threshold for electrical brain stimulation: tolerance and withdrawal changes.
Brain research 1988;459(1):163-7.
1988: M Ukai; Stephen G Holtzman
Effects of beta-funaltrexamine on ingestive behaviors in the rat.
European journal of pharmacology 1988;153(2-3):161-5.
1988: Stephen G Holtzman; I B Finn
Tolerance to behavioral effects of caffeine in rats.
Pharmacology, biochemistry, and behavior 1988;29(2):411-8.
1988: I B Finn; Stephen G Holtzman
Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats.
Life sciences 1988;42(24):2475-82.
1988: M Ukai; Stephen G Holtzman
Restricted feeding does not modify discriminative stimulus effects of morphine in the rat.
Pharmacology, biochemistry, and behavior 1988;29(1):201-3.
1988: J S Andrews; Stephen G Holtzman
Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
Psychopharmacology 1988;94(2):172-7.
1988: M Ukai; Stephen G Holtzman
Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
Psychopharmacology 1988;94(1):32-7.
1987: Jill Adams; J S Andrews; J M Hiller; E J Simon; Stephen G Holtzman
Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats.
Life sciences 1987;41(26):2835-44.
1987: J S Andrews; Stephen G Holtzman
Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats.
Neuropharmacology 1987;26(8):1115-20.
1987: I B Finn; Stephen G Holtzman
Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
Psychopharmacology 1987;93(4):428-34.